David Christopher Mehlin 4
4 · Novo Integrated Sciences, Inc. · Filed Sep 12, 2024
Insider Transaction Report
Form 4
David Christopher Mehlin
DirectorPresident
Transactions
- Award
Stock Option (right to buy)
2024-01-16+200,000→ 200,000 totalExercise: $0.78From: 2024-01-16Exp: 2030-01-16→ Common Stock (200,000 underlying)
Holdings
- 8,195
Class A Common Stock
Footnotes (1)
- [F1]Represents the grant, by the issuer's Board of Directors, of an option to purchase 200,000 shares of the issuer's common stock at an exercise price of $0.78 per share. The option was fully vested and exercisable on the date of grant and is exercisable until January 16, 2030.